Ads
related to: kidney medication names and side effects mayo clinic treatment- What Is PH1?
Learn about primary hyperoxaluria
type 1, and a treatment option.
- Treatment FAQs
Learn about a treatment option
for primary hyperoxaluria type 1.
- Treatment Option
Discover an FDA-approved treatment
for PH1 in children and adults.
- Patient Education Liaison
Ask an Alnylam educator your
questions on a treatment for PH1.
- Patient Support
Find out about Patient Support
Services with Alnylam Assist®.
- Safety Information
Learn about the safety profile
of a treatment option for PH1.
- What Is PH1?
amazon.com has been visited by 1M+ users in the past month
Search results
Results From The WOW.Com Content Network
Midodrine is a prodrug which forms the active metabolite, desglymidodrine, which is an α 1-adrenergic receptor agonist and exerts its actions via activation of α 1-adrenergic receptors of the arteriolar and venous vasculature, producing an increase in vascular tone and elevation of blood pressure.
Prednisolone is a corticosteroid drug with predominant glucocorticoid and low mineralocorticoid activity, making it useful for the treatment of a wide range of inflammatory and autoimmune conditions [17] such as asthma, [18] uveitis, pyoderma gangrenosum, rheumatoid arthritis, urticaria, [19] angioedema, [19] ulcerative colitis, pericarditis ...
Sorafenib, sold under the brand name Nexavar, [3] is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma.
Common side effects include high blood potassium, vomiting, loss of appetite, rash, and headache. [1] The risk of high blood potassium is greater in those with kidney problems, diabetes, and those who are older. [1]
Further work addressing maintenance therapy demonstrated mycophenolate superior to cyclophosphamide, again in terms of response and side-effects. [12] [23] Walsh proposed that mycophenolate should be considered as a first-line induction therapy for treatment of lupus nephritis in people without kidney dysfunction. [24]
Soluble guanylate cyclase (sGC) stimulators are a class of drugs developed to treat heart failure, pulmonary hypertension, and other diseases. The first-in-class medication was riociguat, approved in 2013 for pulmonary hypertension. [1] [2] They have also been investigated for hypertension, systemic sclerosis, and sickle cell disease. [3] [1]
Ads
related to: kidney medication names and side effects mayo clinic treatment